[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100340699":3},{"organization":4,"armGroups":7,"interventions":74,"overallOfficials":108,"centralContacts":112,"locations":118,"responsibleParty":634,"collaborators":80,"id":636,"slug":637,"hasResults":638,"nctId":639,"briefTitle":640,"officialTitle":641,"acronym":80,"eligibilityCriteria":642,"healthyVolunteers":638,"sex":643,"minAge":644,"maxAge":645,"enrollmentInfo":646,"targetDuration":80,"studyType":649,"phases":650,"briefSummary":652,"conditions":653,"keywords":656,"overallStatus":135,"whyStopped":80,"lastUpdateSubmitDate":664,"lastUpdatePostDateStruct":665,"startDateStruct":668,"completionDateStruct":670,"leadSponsor":672,"locationsCount":673},{"fullName":5,"class":6},"Inhibrx Biosciences, Inc","INDUSTRY",[8,14,18,22,26,30,36,43,48,52,56,60,65,70],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose Escalation (Complete)","EXPERIMENTAL","INBRX-109 will be escalated (3+3 design) in subjects with locally advanced or metastatic solid tumors including sarcomas.",[13],"Drug: INBRX-109",{"label":15,"type":10,"description":16,"interventionNames":17},"Expansion Malignant Pleural Mesothelioma (Complete)","Subjects with malignant pleural mesothelioma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Expansion Gastric Adenocarcinoma (Complete)","Subjects with gastric adenocarcinoma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Expansion Colorectal Adenocarcinoma (Complete)","Subjects with colorectal (CRC) adenocarcinoma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Expansion Sarcomas (Complete)","Subjects with certain sarcoma subtypes will be treated with single-agent INBRX-109 at either the MTD or RP2D.",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Combination Expansion Malignant Pleural Mesothelioma (Complete)","Subjects with malignant pleural mesothelioma will be treated with INBRX-109 in combination with chemotherapies (carboplatin, cisplatin, carboplatin and pemetrexed, or cisplatin and pemetrexed)",[13,34,35],"Drug: carboplatin","Drug: pemetrexed",{"label":37,"type":10,"description":38,"interventionNames":39},"Combination Expansion Pancreatic Adenocarcinoma (Complete)","Subjects with pancreatic adenocarcinoma will be treated with INBRX-109 in combination with 5FU\u002Firinotecan based chemotherapy",[13,40,41,42],"Drug: Irinotecan","Drug: Leucovorin","Drug: Fluorouracil",{"label":44,"type":10,"description":45,"interventionNames":46},"Combination Expansion Adult Ewing Sarcoma","Adult subjects with Ewing Sarcoma will be treated with INBRX-109 in combination with irinotecan and temozolomide",[13,40,47],"Drug: Temozolomide",{"label":49,"type":10,"description":50,"interventionNames":51},"Combination Expansion Colorectal Adenocarcinoma (Complete)","Subjects with colorectal adenocarcinoma will be treated with INBRX-109 in combination with FOLFIRI based chemotherapy",[13,40,41,42],{"label":53,"type":10,"description":54,"interventionNames":55},"Expansion Solid Tumors (Complete)","Subjects with Solid tumors and high BMI will be treated with single-agent INBRX-109 at either the MTD or RP2D.",[13],{"label":57,"type":10,"description":58,"interventionNames":59},"Combination Expansion SDH-deficient solid tumors or GIST (Complete)","Subjects with SDH-deficient solid tumors or GIST will be treated with INBRX-109 in combination with temozolomide",[13,47],{"label":61,"type":10,"description":62,"interventionNames":63},"Combination Expansion Colorectal Adenocarcinoma patients with FOLFIRI plus bevacizumab","Colorectal adenocarcinoma will be treated with INBRX-109 with FOLFIRI (FU, leucovorin, and irinotecan) plus bevacizumab",[13,40,41,42,64],"Drug: Bevacizumab",{"label":66,"type":10,"description":67,"interventionNames":68},"Combination Expansion Colorectal Adenocarcinoma with FTD\u002FTPI plus bevacizumab","Colorectal adenocarcinoma will be treated with INBRX-109 with FTD\u002FTPI plus bevacizumab",[13,64,69],"Drug: Trifluridine + Tipiracil",{"label":71,"type":10,"description":72,"interventionNames":73},"Combination Expansion Adolescent Ewing Sarcoma","Adolescent (12 to \\\u003C18) subjects with Ewing Sarcoma will be treated with INBRX-109 in combination with irinotecan and temozolomide",[13,40,47],[75,81,85,88,92,95,98,101,105],{"type":76,"name":77,"description":78,"armGroupLabels":79,"otherNames":80},"DRUG","INBRX-109","Tetravalent DR5 Agonist Antibody",[71,44,49,61,66,31,37,57,9,23,19,15,27,53],null,{"type":76,"name":82,"description":83,"armGroupLabels":84,"otherNames":80},"Irinotecan","Chemotherapy",[71,44,49,61,37],{"type":76,"name":86,"description":83,"armGroupLabels":87,"otherNames":80},"Temozolomide",[71,44,57],{"type":76,"name":89,"description":90,"armGroupLabels":91,"otherNames":80},"carboplatin","chemotherapy",[31],{"type":76,"name":93,"description":90,"armGroupLabels":94,"otherNames":80},"pemetrexed",[31],{"type":76,"name":96,"description":90,"armGroupLabels":97,"otherNames":80},"Leucovorin",[49,61,37],{"type":76,"name":99,"description":90,"armGroupLabels":100,"otherNames":80},"Fluorouracil",[49,61,37],{"type":76,"name":102,"description":103,"armGroupLabels":104,"otherNames":80},"Bevacizumab","targeted therapy",[61,66],{"type":76,"name":106,"description":90,"armGroupLabels":107,"otherNames":80},"Trifluridine + Tipiracil",[66],[109],{"name":110,"affiliation":5,"role":111},"Clinical Lead","STUDY_DIRECTOR",[113],{"name":114,"role":115,"phone":116,"phoneExt":80,"email":117},"Study Director, -Inhibrx","CONTACT","858-500-7833","clinicaltrials@inhibrx.com",[119,133,152,172,187,197,213,229,245,262,272,288,307,322,342,351,368,387,399,416,433,442,459,477,491,503,517,531,544,555,569,578,590,604,613,622],{"facility":120,"status":121,"city":122,"state":123,"zip":124,"country":125,"countryCode":126,"cosmosGeoPoint":127,"geoPoint":132,"contacts":80},"HonorHealth Research Institute","COMPLETED","Scottsdale","Arizona","85258","United States","US",{"type":128,"coordinates":129},"Point",[130,131],-111.89903,33.50921,{"lat":131,"lon":130},{"facility":134,"status":135,"city":136,"state":137,"zip":138,"country":125,"countryCode":126,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"Precision NextGen Oncology and Research","RECRUITING","Beverly Hills","California","90212",{"type":128,"coordinates":140},[141,142],-118.40036,34.07362,{"lat":142,"lon":141},[145,149],{"name":146,"role":115,"phone":147,"phoneExt":80,"email":148},"Francisco Capilla","424-777-0708","Franciscoc@nextgenonc.com",{"name":150,"role":151,"phone":80,"phoneExt":80,"email":80},"Kamalesh Sankhala, MD","PRINCIPAL_INVESTIGATOR",{"facility":153,"status":135,"city":154,"state":137,"zip":155,"country":125,"countryCode":126,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"City of Hope","Duarte","91010",{"type":128,"coordinates":157},[158,159],-117.97729,34.13945,{"lat":159,"lon":158},[162,166,170],{"name":163,"role":115,"phone":164,"phoneExt":80,"email":165},"Heather Lewis","626-256-4673","healewis@coh.org",{"name":167,"role":115,"phone":168,"phoneExt":80,"email":169},"New Patient Services Coordinator","1-800-826-4673","newpatientref@coh.org",{"name":171,"role":151,"phone":80,"phoneExt":80,"email":80},"Marwan Fakih, MD",{"facility":173,"status":135,"city":174,"state":137,"zip":175,"country":125,"countryCode":126,"cosmosGeoPoint":176,"geoPoint":180,"contacts":181},"Valkyrie Clinical Trials","Los Angeles","90067",{"type":128,"coordinates":177},[178,179],-118.24368,34.05223,{"lat":179,"lon":178},[182,185],{"name":183,"role":115,"phone":80,"phoneExt":80,"email":184},"Carla Collier","carla.collier@valkyrieclinicaltrials.com",{"name":186,"role":151,"phone":80,"phoneExt":80,"email":80},"David Berz, MD",{"facility":188,"status":189,"city":190,"state":137,"zip":191,"country":125,"countryCode":126,"cosmosGeoPoint":192,"geoPoint":196,"contacts":80},"University of California, San Diego (UCSD) - Moores Cancer Center","WITHDRAWN","San Diego","92093",{"type":128,"coordinates":193},[194,195],-117.16472,32.71571,{"lat":195,"lon":194},{"facility":198,"status":135,"city":199,"state":137,"zip":200,"country":125,"countryCode":126,"cosmosGeoPoint":201,"geoPoint":205,"contacts":206},"University of California, San Francisco (UCSF)","San Francisco","94110",{"type":128,"coordinates":202},[203,204],-122.41942,37.77493,{"lat":204,"lon":203},[207,211],{"name":208,"role":115,"phone":209,"phoneExt":80,"email":210},"Lisa Tan","415-866-7866","lisa.tan@ucsf.edu",{"name":212,"role":151,"phone":80,"phoneExt":80,"email":80},"Varun Monga, MD",{"facility":214,"status":135,"city":215,"state":137,"zip":216,"country":125,"countryCode":126,"cosmosGeoPoint":217,"geoPoint":221,"contacts":222},"Sarcoma Oncology Center","Santa Monica","90403",{"type":128,"coordinates":218},[219,220],-118.49138,34.01949,{"lat":220,"lon":219},[223,227],{"name":224,"role":115,"phone":225,"phoneExt":80,"email":226},"Victoria Chua-Alcala","310-552-9999","vchua@sarcomaoncology.com",{"name":228,"role":151,"phone":80,"phoneExt":80,"email":80},"Sant P Chawla, MD",{"facility":230,"status":135,"city":231,"state":232,"zip":233,"country":125,"countryCode":126,"cosmosGeoPoint":234,"geoPoint":238,"contacts":239},"University of Colorado Hospital","Aurora","Colorado","80045",{"type":128,"coordinates":235},[236,237],-104.83192,39.72943,{"lat":237,"lon":236},[240,243],{"name":241,"role":115,"phone":80,"phoneExt":80,"email":242},"Michaela Riley","michaela.riley@cuanschutz.edu",{"name":244,"role":151,"phone":80,"phoneExt":80,"email":80},"Christopher Lieu, MD",{"facility":246,"status":135,"city":247,"state":248,"zip":249,"country":125,"countryCode":126,"cosmosGeoPoint":250,"geoPoint":254,"contacts":255},"Emory University - Winship Cancer Institute","Atlanta","Georgia","30322",{"type":128,"coordinates":251},[252,253],-84.38798,33.749,{"lat":253,"lon":252},[256,260],{"name":257,"role":115,"phone":258,"phoneExt":80,"email":259},"Kimberly Homere","404-778-6583","kimberly.homere@emory.edu",{"name":261,"role":151,"phone":80,"phoneExt":80,"email":80},"Olatunji Alese, MD",{"facility":263,"status":121,"city":264,"state":265,"zip":266,"country":125,"countryCode":126,"cosmosGeoPoint":267,"geoPoint":271,"contacts":80},"The University of Chicago","Chicago","Illinois","60637",{"type":128,"coordinates":268},[269,270],-87.65005,41.85003,{"lat":270,"lon":269},{"facility":273,"status":135,"city":274,"state":275,"zip":276,"country":125,"countryCode":126,"cosmosGeoPoint":277,"geoPoint":281,"contacts":282},"University of Michigan","Ann Arbor","Michigan","48109",{"type":128,"coordinates":278},[279,280],-83.74088,42.27756,{"lat":280,"lon":279},[283,286],{"name":284,"role":115,"phone":80,"phoneExt":80,"email":285},"Myron Hepner","mhepner@med.umich.edu",{"name":287,"role":151,"phone":80,"phoneExt":80,"email":80},"Rashmi Chugh, MD",{"facility":289,"status":135,"city":290,"state":275,"zip":291,"country":125,"countryCode":126,"cosmosGeoPoint":292,"geoPoint":296,"contacts":297},"START Midwest Michigan, PC","Grand Rapids","49546",{"type":128,"coordinates":293},[294,295],-85.66809,42.96336,{"lat":295,"lon":294},[298,302,305],{"name":299,"role":115,"phone":300,"phoneExt":80,"email":301},"Julie Burns","616-954-5559","julie.burns@startmidwest.com",{"name":303,"role":115,"phone":80,"phoneExt":80,"email":304},"Leland Rouse","leland.rouse@startmidwest.com",{"name":306,"role":151,"phone":80,"phoneExt":80,"email":80},"Nehal Lakhani, MD",{"facility":308,"status":135,"city":309,"state":309,"zip":310,"country":125,"countryCode":126,"cosmosGeoPoint":311,"geoPoint":315,"contacts":316},"David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center","New York","10021",{"type":128,"coordinates":312},[313,314],-74.00597,40.71427,{"lat":314,"lon":313},[317,320],{"name":318,"role":115,"phone":319,"phoneExt":80,"email":80},"Care Advisors","833-675-5437",{"name":321,"role":151,"phone":80,"phoneExt":80,"email":80},"Emily Slotkin, MD",{"facility":323,"status":135,"city":324,"state":325,"zip":326,"country":125,"countryCode":126,"cosmosGeoPoint":327,"geoPoint":331,"contacts":332},"Cincinnati Children's Hospital Medical Center","Cincinnati","Ohio","45229",{"type":128,"coordinates":328},[329,330],-84.51439,39.12711,{"lat":330,"lon":329},[333,337,341],{"name":334,"role":115,"phone":335,"phoneExt":80,"email":336},"Michael D Deel, MD","513-636-3200","michael.deel@cchmc.org",{"name":338,"role":115,"phone":339,"phoneExt":80,"email":340},"Lori Backus, BA","513-636-2047","Lori.backus@cchmc.org",{"name":334,"role":151,"phone":80,"phoneExt":80,"email":80},{"facility":343,"status":121,"city":344,"state":325,"zip":345,"country":125,"countryCode":126,"cosmosGeoPoint":346,"geoPoint":350,"contacts":80},"Cleveland Clinic","Cleveland","44195",{"type":128,"coordinates":347},[348,349],-81.69541,41.4995,{"lat":349,"lon":348},{"facility":352,"status":135,"city":353,"state":354,"zip":355,"country":125,"countryCode":126,"cosmosGeoPoint":356,"geoPoint":360,"contacts":361},"Oregon Health & Science University","Portland","Oregon","97239",{"type":128,"coordinates":357},[358,359],-122.67621,45.52345,{"lat":359,"lon":358},[362,366],{"name":363,"role":115,"phone":364,"phoneExt":80,"email":365},"Zach Nelson","503-494-0833","nelsonz@ohsu.edu",{"name":367,"role":151,"phone":80,"phoneExt":80,"email":80},"Michael Heinrich, MD",{"facility":369,"status":135,"city":370,"state":371,"zip":372,"country":125,"countryCode":126,"cosmosGeoPoint":373,"geoPoint":377,"contacts":378},"Children's Hospital of Philadelphia- Center for Childhood Cancer Research","Philadelphia","Pennsylvania","19104",{"type":128,"coordinates":374},[375,376],-75.16362,39.95238,{"lat":376,"lon":375},[379,383,385],{"name":380,"role":115,"phone":381,"phoneExt":80,"email":382},"Matthew Stein","267-425-3169","steinm3@chop.edu",{"name":80,"role":115,"phone":80,"phoneExt":80,"email":384},"precisionmedicinetrialscoordinators@chop.edu",{"name":386,"role":151,"phone":80,"phoneExt":80,"email":80},"Theodore Laetsch, MD",{"facility":388,"status":135,"city":370,"state":371,"zip":389,"country":125,"countryCode":126,"cosmosGeoPoint":390,"geoPoint":392,"contacts":393},"University of Pennsylvania Abramson Cancer Center","19106",{"type":128,"coordinates":391},[375,376],{"lat":376,"lon":375},[394,397],{"name":395,"role":115,"phone":80,"phoneExt":80,"email":396},"Sarcoma Research","SarcomaResearch@uphs.upenn.edu",{"name":398,"role":151,"phone":80,"phoneExt":80,"email":80},"Lee Hartner, MD",{"facility":400,"status":135,"city":401,"state":402,"zip":403,"country":125,"countryCode":126,"cosmosGeoPoint":404,"geoPoint":408,"contacts":409},"Vanderbilt University School of Medicine","Nashville","Tennessee","37232",{"type":128,"coordinates":405},[406,407],-86.78444,36.16589,{"lat":407,"lon":406},[410,414],{"name":411,"role":115,"phone":412,"phoneExt":80,"email":413},"Samrah Ahmed","615.936.9598","samrah.ahmed@vumc.org",{"name":415,"role":151,"phone":80,"phoneExt":80,"email":80},"Elizabeth Davis, MD",{"facility":417,"status":135,"city":418,"state":419,"zip":420,"country":125,"countryCode":126,"cosmosGeoPoint":421,"geoPoint":425,"contacts":426},"UT MD Anderson Cancer Center","Houston","Texas","77030",{"type":128,"coordinates":422},[423,424],-95.36327,29.76328,{"lat":424,"lon":423},[427,431],{"name":428,"role":115,"phone":429,"phoneExt":80,"email":430},"Emily Scott","(713) 745-2243","EMScott1@mdanderson.org",{"name":432,"role":151,"phone":80,"phoneExt":80,"email":80},"David Hong, MD",{"facility":434,"status":121,"city":435,"state":419,"zip":436,"country":125,"countryCode":126,"cosmosGeoPoint":437,"geoPoint":441,"contacts":80},"NEXT Oncology","San Antonio","78229",{"type":128,"coordinates":438},[439,440],-98.49363,29.42412,{"lat":440,"lon":439},{"facility":443,"status":135,"city":444,"state":445,"zip":446,"country":125,"countryCode":126,"cosmosGeoPoint":447,"geoPoint":451,"contacts":452},"University of Virginia","Charlottesville","Virginia","22903",{"type":128,"coordinates":448},[449,450],-78.47668,38.02931,{"lat":450,"lon":449},[453,457],{"name":454,"role":115,"phone":455,"phoneExt":80,"email":456},"Sarah Sommer","434-924-7613","ss2vz@uvahealth.org",{"name":458,"role":151,"phone":80,"phoneExt":80,"email":80},"Ludimila Cavalcante, MD",{"facility":460,"status":135,"city":461,"state":445,"zip":462,"country":125,"countryCode":126,"cosmosGeoPoint":463,"geoPoint":467,"contacts":468},"NEXT Oncology - Virginia","Fairfax","22031",{"type":128,"coordinates":464},[465,466],-77.30637,38.84622,{"lat":466,"lon":465},[469,473,475],{"name":470,"role":115,"phone":471,"phoneExt":80,"email":472},"Anthony Young","703-783-4536","ayoung@nextoncology.com",{"name":80,"role":115,"phone":80,"phoneExt":80,"email":474},"NXTVIR_Coordinators@nextoncology.com",{"name":476,"role":151,"phone":80,"phoneExt":80,"email":80},"Alexander Spira, MD",{"facility":478,"status":135,"city":479,"state":80,"zip":480,"country":481,"countryCode":482,"cosmosGeoPoint":483,"geoPoint":487,"contacts":488},"Centre Leon Berard","Lyon","69008","France","FR",{"type":128,"coordinates":484},[485,486],4.84789,45.74906,{"lat":486,"lon":485},[489],{"name":490,"role":151,"phone":80,"phoneExt":80,"email":80},"Mehdi Brahmi, MD",{"facility":492,"status":135,"city":493,"state":80,"zip":494,"country":481,"countryCode":482,"cosmosGeoPoint":495,"geoPoint":499,"contacts":500},"Gustave Roussy","Villejuif","94805",{"type":128,"coordinates":496},[497,498],2.35992,48.7939,{"lat":498,"lon":497},[501],{"name":502,"role":151,"phone":80,"phoneExt":80,"email":80},"Pablo Berlanga, MD",{"facility":504,"status":135,"city":505,"state":80,"zip":506,"country":507,"countryCode":508,"cosmosGeoPoint":509,"geoPoint":513,"contacts":514},"La Fondazione e l'Istituto di Candiolo","Candiolo","10060","Italy","IT",{"type":128,"coordinates":510},[511,512],7.59812,44.95858,{"lat":512,"lon":511},[515],{"name":516,"role":151,"phone":80,"phoneExt":80,"email":80},"Sandra Aliberti, MD",{"facility":518,"status":135,"city":519,"state":80,"zip":520,"country":507,"countryCode":508,"cosmosGeoPoint":521,"geoPoint":525,"contacts":526},"Fondazione IRCCS Istituto Nazionale dei Tumori","Milan","20123",{"type":128,"coordinates":522},[523,524],9.18951,45.46427,{"lat":524,"lon":523},[527,529],{"name":528,"role":151,"phone":80,"phoneExt":80,"email":80},"Salvatore Provenzano, MD",{"name":530,"role":151,"phone":80,"phoneExt":80,"email":80},"Roberto Luksch, MD",{"facility":532,"status":135,"city":533,"state":80,"zip":80,"country":534,"countryCode":535,"cosmosGeoPoint":536,"geoPoint":540,"contacts":541},"University Medical Center Groningen","Groningen","Netherlands","NL",{"type":128,"coordinates":537},[538,539],6.56667,53.21917,{"lat":539,"lon":538},[542],{"name":543,"role":151,"phone":80,"phoneExt":80,"email":80},"Jacco de Haan, MD",{"facility":545,"status":135,"city":546,"state":80,"zip":80,"country":534,"countryCode":535,"cosmosGeoPoint":547,"geoPoint":551,"contacts":552},"Academisch Ziekenhuis Leiden","Leiden",{"type":128,"coordinates":548},[549,550],4.49306,52.15833,{"lat":550,"lon":549},[553],{"name":554,"role":151,"phone":80,"phoneExt":80,"email":80},"André (Hans) Gelderblom, MD",{"facility":556,"status":135,"city":557,"state":80,"zip":558,"country":559,"countryCode":560,"cosmosGeoPoint":561,"geoPoint":565,"contacts":566},"Hospital Universitario Vall d'Hebron","Barcelona","08035","Spain","ES",{"type":128,"coordinates":562},[563,564],2.15899,41.38879,{"lat":564,"lon":563},[567],{"name":568,"role":151,"phone":80,"phoneExt":80,"email":80},"Elena Elez, MD",{"facility":570,"status":135,"city":557,"state":80,"zip":571,"country":559,"countryCode":560,"cosmosGeoPoint":572,"geoPoint":574,"contacts":575},"Hospital de la Santa Creu i Sant Pau","08041",{"type":128,"coordinates":573},[563,564],{"lat":564,"lon":563},[576],{"name":577,"role":151,"phone":80,"phoneExt":80,"email":80},"Ana Sebio Garcia, MD",{"facility":579,"status":135,"city":580,"state":80,"zip":581,"country":559,"countryCode":560,"cosmosGeoPoint":582,"geoPoint":586,"contacts":587},"Hospital Clinico San Carlos","Madrid","28040",{"type":128,"coordinates":583},[584,585],-3.70256,40.4165,{"lat":585,"lon":584},[588],{"name":589,"role":151,"phone":80,"phoneExt":80,"email":80},"Antonio Casado Herraez",{"facility":591,"status":135,"city":592,"state":80,"zip":593,"country":594,"countryCode":595,"cosmosGeoPoint":596,"geoPoint":600,"contacts":601},"Great North Children's Hospital","London","EC4V 3BJ","United Kingdom","UK",{"type":128,"coordinates":597},[598,599],-0.12574,51.50853,{"lat":599,"lon":598},[602],{"name":603,"role":151,"phone":80,"phoneExt":80,"email":80},"Quentin Campbell-Hewson, MD",{"facility":605,"status":135,"city":592,"state":80,"zip":606,"country":594,"countryCode":595,"cosmosGeoPoint":607,"geoPoint":609,"contacts":610},"University College London Hospital","NW1 2PG",{"type":128,"coordinates":608},[598,599],{"lat":599,"lon":598},[611],{"name":612,"role":151,"phone":80,"phoneExt":80,"email":80},"Sandra Strauss, MD",{"facility":614,"status":135,"city":592,"state":80,"zip":615,"country":594,"countryCode":595,"cosmosGeoPoint":616,"geoPoint":618,"contacts":619},"The Royal Marsden NHS Foundation Trust","SW3 6JJ",{"type":128,"coordinates":617},[598,599],{"lat":599,"lon":598},[620],{"name":621,"role":151,"phone":80,"phoneExt":80,"email":80},"Andrea Napolitano, MD",{"facility":623,"status":135,"city":624,"state":80,"zip":625,"country":594,"countryCode":595,"cosmosGeoPoint":626,"geoPoint":630,"contacts":631},"Royal Manchester Children's Hospital","Manchester","M13 9WL",{"type":128,"coordinates":627},[628,629],-2.23743,53.48095,{"lat":629,"lon":628},[632],{"name":633,"role":151,"phone":80,"phoneExt":80,"email":80},"Bernadette Maria Dymphna Brennan",{"type":635,"investigatorFullName":80,"investigatorTitle":80,"investigatorAffiliation":80,"oldNameTitle":80,"oldOrganization":80},"SPONSOR","100340699","phase-1-phase-1-study-of-inbrx-109-in-subjects-with-locally-advanced-or-metastatic-solid-tumors-including-sarcomas-100340699",false,"NCT03715933","Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas","An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas","Inclusion Criteria:\n\n1. Males or females aged ≥12 to less than 85 years for Ewing sarcoma and 18 to less than 85 years of age for other tumors.\n2. Part 3 combination therapy expansion tumor types:\n\n   * Histologically confirmed Ewing sarcoma with a classical fusion: Patients with locally advanced or metastatic, unresectable, relapsed, or refractory disease who have received at least 1 but no more than 2 prior lines of systemic treatment with a preferred first line chemotherapy regimens.\n   * Colorectal adenocarcinoma: Patients who have failed 1 (one) prior line of systemic therapy that did not include irinotecan.\n   * Colorectal adenocarcinoma: Patients who have failed 2 but no more than 3 prior lines of systemic therapy and are FTD\u002FTPI-naïve.\n3. Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria.\n4. Adequate hematologic, coagulation, hepatic and renal function as defined per protocol.\n5. Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1, or Karnofsky Performance Status score of ≥60, or Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years).\n6. Estimated life expectancy of at least 12 weeks.\n7. Availability of archival tissue or fresh cancer biopsy are mandatory.\n\nExclusion Criteria:\n\n1. Prior treatment with or exposure to DR5 agonists.\n2. Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment. Exceptions per protocol.\n3. Allergy or sensitivity to INBRX-109 or known allergies to CHO-produced antibodies.\n4. Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment, and liver-directed within 12 months prior to the first dose of study drug.\n5. Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years. Exceptions per protocol.\n6. Prior or concurrent malignancies. Exceptions per protocol.\n7. Hematologic malignancies.\n8. Symptomatic active primary CNS tumors, leptomeningeal disease, and CNS metastases. Exceptions per protocol. Patients with any evidence or history of multiple sclerosis (MS) or other demyelinating disorders are excluded.\n9. Chronic liver diseases including fatty liver. Exception: Patients \\\u003C 45 years old with fatty liver disease may be accepted as long as adequate hepatic function as defined in the inclusion\u002Fexclusion criteria is confirmed.\n10. Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.\n11. Evidence or history of hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection.\n12. Known sensitivity or contraindications to the following drugs:\n\n    * Ewing sarcoma: irinotecan or TMZ\n    * colorectal adenocarcinoma: FU, leucovorin, irinotecan, bevacizumab or FTP\u002FTPI\n13. Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.\n14. Acute, hemodynamically significant deep vein thrombosis or clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment.\n15. Major surgery within 4 weeks prior to enrollment on this trial.\n16. Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.\n17. Other exclusion criteria per protocol.","ALL","12 Years","85 Years",{"count":647,"type":648},411,"ESTIMATED","INTERVENTIONAL",[651],"PHASE1","This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5).",[654,655],"Ewing Sarcoma","Colorectal Adenocarcinoma",[657,658,659,660,661,654,662,663],"Phase 1","Phase 1 Clinical Trial","Solid Tumors","Sarcoma","DR5","CRC","colorectal adenocarcinoma","2026-05-20",{"date":666,"type":667},"2026-05-22","ACTUAL",{"date":669,"type":667},"2018-10-08",{"date":671,"type":648},"2029-06",{"name":5,"class":6},36]